Charles Langelier

Associate Professor

UCSF Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Year:

2026

Year:

2026

Year:

2026

In the general population, aging is associated with an increase in systemic inflammation and chronic disease burden. However, in systemic lupus erythematosus (SLE), older age is uniquely associated with a decrease in disease activity, suggesting a distinct relationship between aging and inflammation. Using a multiomic approach, we compared aging-related changes in the peripheral blood immune profiles of 287 patients with SLE and 928 healthy controls. In patients with SLE, aging correlated with lower expression of interferon (IFN)–stimulated genes (ISGs) across multiple cell types, decreased plasma IFN-α2, and differential genome methylation. Both patients with SLE and controls demonstrated age-related declines in naïve T cells, but only patients with SLE exhibited increases in CD56 dim natural killer cells with older age. Of the genes both down-regulated and hypermethylated with older age, ISGs were disproportionately represented, suggesting a role for epigenetic silencing. Altogether, we found that patients with SLE exhibit unique aging-related decreases in IFN signaling that correlate with improved disease activity.

Year:

2025

Lower respiratory tract infections (LRTI) are a leading cause of mortality and are challenging to diagnose in critically ill patients, as non-infectious causes of respiratory failure can present with similar clinical features. We develop an LRTI diagnostic method combining the pulmonary transcriptomic biomarker FABP4 with electronic medical record text assessment using the large language model Generative Pre-trained Transformer 4. In a cohort of critically ill adults, a combined classifier incorporating FABP4 expression and large language model electronic medical record analysis achieves an area under the receiver operating characteristic curve (AUC) of 0.93 ± 0.08 and an accuracy of 84%, outperforming FABP4 expression alone (0.84 ± 0.11) and large language model-based analysis alone (0.83 ± 0.07). By comparison, the medical team admission diagnosis has an accuracy of 72%. In an independent validation cohort, the combined classifier yields an AUC of 0.98 ± 0.04 and accuracy of 96%. This study suggests that integrating a host biomarker with large language model analysis can improve LRTI diagnosis in critically ill adults.

Year:

2025

Accurately distinguishing lower respiratory tract infection (LRTI) from incidental pathogen carriage (IPC) is clinically challenging. The host immunologic and microbial factors that define the states of LRTI and IPC are poorly understood. We performed host-microbe metatranscriptomic profiling of tracheal aspirate from 326 mechanically ventilated children with clinically adjudicated LRTI (n = 207), IPC (n = 70), or non-infectious acute respiratory illnesses (n = 49). In the airway microbiome, LRTI was characterized by reduced alpha diversity and taxonomic richness, while IPC was characterized greater total bacterial abundance, enrichment in respiratory anaerobes and increased metabolic activity. In terms of host response, patients with LRTI exhibited a distinct lower airway transcriptional signature of innate and adaptive immune activation compared to those with IPC, who had similar transcriptional profiles as uninfected controls. Mediation analyses suggested that the airway microbiome influences the host response to pathogens. An integrated host-microbe metatranscriptomic classifier discriminated LRTI from IPC and controls with an AUC = 0.89 (95% confidence interval (CI) 0.85–0.92). The single gene FABP4 , when combined with alpha diversity, performed similarly, and FABP4 protein alone achieved an AUC = 0.88 (95% CI 0.82–0.93). Together, our findings reveal distinct ecological and immunologic archetypes that define LRTI and IPC, and support data-driven, biology-informed LRTI diagnostics that incorporate host and microbe.

Year:

2025

Accurately distinguishing lower respiratory tract infection (LRTI) from incidental pathogen carriage (IPC) is clinically challenging. The host immunologic and microbial factors that define the states of LRTI and IPC are poorly understood. We performed host-microbe metatranscriptomic profiling of tracheal aspirate from 326 mechanically ventilated children with clinically adjudicated LRTI (n=207), IPC (n=70), or non-infectious acute respiratory illnesses (n=49). In the airway microbiome, LRTI was characterized by reduced alpha diversity and taxonomic richness, while IPC was characterized greater total bacterial abundance, enrichment in respiratory anaerobes and increased metabolic activity. In terms of host response, patients with LRTI exhibited a distinct lower airway transcriptional signature of innate and adaptive immune activation compared to those with IPC, who had similar transcriptional profiles as uninfected controls. Mediation analyses suggested that the airway microbiome influences the host response to pathogens. An integrated host-microbe metatranscriptomic classifier discriminated LRTI from IPC and controls with an AUC=0.89 (95% confidence interval (CI) 0.85-0.92). The single gene FABP4, when combined with alpha diversity, performed similarly, and FABP4 protein alone achieved an AUC=0.88 (95% CI 0.82-0.93). Together, our findings reveal distinct ecological and immunologic archetypes that define LRTI and IPC, and support data-driven, biology-informed LRTI diagnostics that incorporate host and microbe.

Year:

2025

Sepsis is a major global cause of morbidity and mortality, yet therapeutic progress has been hindered by profound heterogeneity in the host immune response. To address this, we integrated five publicly available single-cell RNA sequencing (scRNAseq) datasets from adult sepsis patients alongside healthy controls from the Tabula Sapiens project. Our integrated analysis across datasets enabled cell subtype-resolved profiling of the septic immune response. In patients with whole blood–derived scRNAseq data, we identified a dominant role for Neutrophil (Neu) progenitors and subsets in defining pathobiology of detrimental sepsis subtypes, with broad concordance noted across frameworks. Intercellular communication analyses further revealed both conserved and subtype-specific ligand–receptor signaling networks. These findings highlight the critical importance of harmonized sepsis subtyping and integrated multi-omics approaches to uncover actionable immunologic mechanisms. Our study lays the groundwork for advancing precision immunomodulatory therapies in critically ill patients with sepsis.

Year:

2025

Tools for rapid identification of novel and/or emerging viruses are urgently needed for clinical diagnosis of unexplained infections and pandemic preparedness. Here we developed and clinically validated a largely automated metagenomic next-generation sequencing (mNGS) assay for agnostic detection of respiratory viral pathogens from upper respiratory swab and bronchoalveolar lavage samples in <24 h. The mNGS assay achieved mean limits of detection of 543 copies/mL, viral load quantification with 100% linearity, and 93.6% sensitivity, 93.8% specificity, and 93.7% accuracy compared to gold-standard clinical multiplex RT-PCR testing. Performance increased to 97.9% overall predictive agreement after discrepancy testing and clinical adjudication, which was superior to that of RT-PCR (95.0% agreement). To enable discovery of novel, sequence-divergent human viruses with pandemic potential, de novo assembly and translated nucleotide algorithms were incorporated into the automated SURPI+ computational pipeline used by the mNGS assay for pathogen detection. Using in silico analysis, we showed that after removal of all human viral sequences from the reference database, 70 (100%) of 70 representative human viral pathogens could still be identified based on homology to related animal or plant viruses. Our assay, which was granted breakthrough device designation from the US Food and Drug Administration (FDA) in August of 2023, demonstrates the feasibility of routine mNGS testing in clinical and public health laboratories, thus facilitating a robust and rapid response to the next viral pandemic.

Year:

2024

Viral lower respiratory tract infection (vLRTI) is a leading cause of hospitalization and death in children worldwide. Despite this, no studies have employed proteomics to characterize host immune responses to severe pediatric vLRTI in both the lower airway and systemic circulation. To address this gap, gain insights into vLRTI pathophysiology, and test a novel diagnostic approach, we assayed 1,305 proteins in tracheal aspirate (TA) and plasma from 62 critically ill children using SomaScan. We performed differential expression (DE) and pathway analyses comparing vLRTI (n=40) to controls with non-infectious acute respiratory failure (n=22), developed a diagnostic classifier using LASSO regression, and analyzed matched TA and plasma samples. We further investigated the impact of viral load and bacterial coinfection on the proteome. The TA signature of vLRTI was characterized by 200 DE proteins (P adj <0.05) with upregulation of interferons and T cell responses and downregulation of inflammation-modulating proteins including FABP and MIP-5. A nine-protein TA classifier achieved an AUC of 0.96 (95% CI 0.90-1.00) for identifying vLRTI. In plasma, the host response to vLRTI was more muted with 56 DE proteins. Correlation between TA and plasma was limited, although ISG15 was elevated in both compartments. In bacterial coinfection, we observed increases in the TNF-stimulated protein TSG-6, as well as CRP, and interferon-related proteins. Viral load correlated positively with interferon signaling and negatively with neutrophil-activation pathways. Taken together, our study provides fresh insight into the lower airway and systemic proteome of severe pediatric vLRTI, and identifies novel protein biomarkers with diagnostic potential. IMPORTANCE We describe the first proteomic profiling of the lower airway and blood in critically ill children with severe viral lower respiratory tract infection (vLRTI). From tracheal aspirate (TA), we defined a proteomic signature of vLRTI characterized by increased expression of interferon signaling proteins and decreased expression of proteins involved in immune modulation including FABP and MIP-5. Using machine learning, we developed a parsimonious diagnostic classifier that distinguished vLRTI from non-infectious respiratory failure with high accuracy. Comparative analysis of paired TA and plasma specimens demonstrated limited concordance, although the interferon-stimulated protein ISG15 was significantly upregulated with vLRTI in both compartments. We further identified TSG-6 and CRP as airway biomarkers of bacterial-viral coinfection, and viral load analyses demonstrated positive correlation with interferon-related protein expression and negative correlation with the expression of neutrophil activation proteins. Taken together, our study provides new insight into the lower airway and systemic proteome of severe pediatric vLRTI.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (24)

Michael A. Matthay

University of California

UNITED STATES
View details

Peter Mourani

Professor

University of Arkansas for Medical Sciences

UNITED STATES
View details

Aline Maddux

Associate Professor of Pediatrics

-

UNITED STATES
View details

David Erle

Professor

University of California, San Francisco

UNITED STATES
View details

Joseph L. DeRisi

University of California

UNITED STATES
View details

Charles Chiu

Associate Professor

University of California San Francisco School of Medicine

UNITED STATES
View details

Andrew McArthur

Professor

McMaster University

CANADA
View details

Mark Snyder

Assistant Professor

University of Pittsburgh

UNITED STATES
View details

Aartik Sarma

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Beth Shoshana Zha

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Lisa F. Barcellos

University of California

UNITED STATES
View details

Marina Sirota

University of California, San Francisco

UNITED STATES
View details

Matthew Leroue

Assistant Professor

University of Colorado School of Medicine

UNITED STATES
View details

Victoria Chu

University of California, San Francisco

UNITED STATES
View details

Lilliam Ambroggio

Professor

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Chun Jimmie Ye

University of California

UNITED STATES
View details

Padmini Deosthale

University of California, San Francisco

UNITED STATES
View details

Lieuwe D. J. Bos

University of Amsterdam

NETHERLANDS
View details

Brendon Scicluna

Senior Lecturer

University of Malta

View details

Mihir Atreya

Research Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Michael Woodworth

Associate Professor

Emory University School of Medicine

UNITED STATES
View details

Gabriela Fragiadakis

Associate Professor

University of California, San Francisco

UNITED STATES
View details

Purvesh Khatri

Professor

Stanford University School of Medicine

UNITED STATES
View details

Patrick McQuillen

Professor

University of California, San Francisco

UNITED STATES
View details